A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2022 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-30

Study Completion Date

2023-02-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a non-interventional study of remazolam toluenesulfonate (rebenin ®) for injection in Chinese patients. A total of 2000 patients were enrolled in this study based on the preliminary safety assessment of rebenin ®, and all safety information was obtained

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures

NCT06216444

Sedation in Non-intubated Diagnostic and Therapeutic Procedures

NOT_YET_RECRUITING PHASE4

A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers

NCT01970072

Healthy

COMPLETED PHASE1

Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy

NCT04656964

Elderly Patients Gastrointestinal Endoscopy Midazolam +1 more

COMPLETED NA

A Study of Remimazolam Tosilate for Sedation in the ICU

NCT05152303

Sedation in the ICU

COMPLETED PHASE2

Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy

NCT00869440

Procedural Sedation Endoscopy

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroscopic and Colonoscopic Sedation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort 1

Painless gastroscopic sedation cohort

Remimazolam Tosilate for Injection

Intervention Type DRUG

Remimazolam Tosilate for Injection

Cohort 2

Painless colonoscopy sedation cohort

Remimazolam Tosilate for Injection

Intervention Type DRUG

Remimazolam Tosilate for Injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remimazolam Tosilate for Injection

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Use rebenin ® for painless gastroscopic sedation and painless colonoscopic sedation
2. Patients need to sign informed consent

Exclusion Criteria

1. Patients who are participating in or planning to participate in any interventional clinical trial
2. The investigator considers that there are any other reasons for the patient's ineligibility for the study

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes